IPD Analytics

Q: 如果IPD Analytics在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載IPD Analytics。

Q: 運行IPD Analytics的最低配置要求是什麼？

以下為IPD Analytics的最低配置要求。<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

免費

1.9for iPhone, iPad

IPD Analytics, LLC

Developer

2025年09月07日

Update Date

Business

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

IPD Analytics 螢幕截圖

iPad

iPhone

About IPD Analytics

IPD Analytics, the industry-leader in drug life-cycle insights, brings clarity to pharmacy and therapeutics management, with podcasts outlining tactical strategies for formulary optimization, drug pipeline planning, and clinical, contracting, and market-access decision making.

With the IPD Analytics App, access a library of podcasts and transcripts featuring our Executive Clinical Pharmacy team, who discuss:
- Hot topics surrounding high-cost and complex drugs
- Impactful generic, brand, and biosimilar launches coming down the pipeline
- Strategies to improve outcomes, lower pharmacy spend, and optimize formulary design
- Popular questions frequently asked by payers, providers, and drug manufacturers across the United States